Literature DB >> 34567948

Successful treatment of cervical and upper thoracic esophageal adenocarcinoma using induction chemotherapy followed by surgery: a case report.

Takeharu Imai1, Yoshihiro Tanaka1, Hidenori Ojio1, Yuta Sato1, Tomonari Suetsugu1, Masahiro Fukada1, Itaru Yasufuku1, Yoshinori Iwata1, Hisashi Imai1, Naoki Okumura1, Nobuhisa Matsuhashi1, Takao Takahashi1, Kei Noguchi2, Tatsuhiko Miyazaki2, Kazuhiro Yoshida1.   

Abstract

Cervical esophageal adenocarcinoma has a low incidence rate and its treatment involves various strategies. We report a patient with locally advanced cervical to upper esophageal adenocarcinoma who was able to undergo induction chemotherapy and radical surgery. A 55-year-old man was diagnosed with a poorly differentiated adenocarcinoma between the cervical and upper thoracic esophagus. The primary lesion had infiltrated into the tracheal membrane and had metastasized into the cervical lymph nodes. The initial diagnosis was T4bN1M1 stage IVB. The lower edge of the tumor was close to the tracheal bifurcation, making it difficult to create a longitudinal tracheal foramen during surgery. Therefore, when biweekly-DCF therapy was performed as induction chemotherapy, the tumor shrank sufficiently and its infiltration into the tracheal membrane decreased subsequently. We performed total laryngopharyngoesophagectomy with three-field lymph node dissection and reconstruction using free jejunal grafts and subtotal stomach via a posterior mediastinum route and a permanent tracheal foramen as a radical surgery. The pathological diagnosis was T2/MP, N1, and the effect of chemotherapy was grade 2. Cervical esophageal adenocarcinoma was rare, but technically reliable and safe oncologic surgery was possible after induction chemotherapy. © The Japan Society of Clinical Oncology 2021.

Entities:  

Keywords:  Cervical esophageal adenocarcinoma; Induction chemotherapy; Total laryngopharyngoesophagectomy

Year:  2021        PMID: 34567948      PMCID: PMC8421492          DOI: 10.1007/s13691-021-00505-y

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  14 in total

Review 1.  Are squamous and adenocarcinomas of the esophagus the same disease?

Authors:  J Rüdiger Siewert; Katja Ott
Journal:  Semin Radiat Oncol       Date:  2007-01       Impact factor: 5.934

Review 2.  Adenocarcinoma of the cervical esophagus arising from ectopic gastric mucosa: report of two cases and review of the literature.

Authors:  Kosuke Nomura; Toshiro Iizuka; Naoko Inoshita; Yasutaka Kuribayashi; Takahito Toba; Akihiro Yamada; Satoshi Yamashita; Tsukasa Furuhata; Daisuke Kikuchi; Akira Matsui; Toshifumi Mitani; Osamu Ogawa; Shu Hoteya; Masaki Ueno; Harushi Udagawa; Mitsuru Kaise
Journal:  Clin J Gastroenterol       Date:  2015-12

Review 3.  Adenocarcinoma of the esophagus: controversies and consensus.

Authors:  David H Ilson
Journal:  Chin Clin Oncol       Date:  2017-10

4.  Esophageal adenocarcinoma that probably originated in the esophageal gland duct: a case report.

Authors:  Y Endoh; M Miyawaki; G Tamura; H Watanabe; T Motoyama
Journal:  Pathol Int       Date:  1999-02       Impact factor: 2.534

Review 5.  Esophageal adenocarcinomas in heterotopic gastric mucosa: review and report of a case with complete response to neoadjuvant radiochemotherapy.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Karen Becker; Rüdiger J Siewert
Journal:  Dig Surg       Date:  2005-04-20       Impact factor: 2.588

Review 6.  Oesophageal cancer.

Authors:  Jesper Lagergren; Elizabeth Smyth; David Cunningham; Pernilla Lagergren
Journal:  Lancet       Date:  2017-06-22       Impact factor: 79.321

7.  A case of esophageal adenocarcinoma arising from the ectopic gastric mucosa in the thoracic esophagus.

Authors:  Shuji Komori; Shinji Osada; Yoshihiro Tanaka; Takao Takahashi; Narutoshi Nagao; Kazuya Yamaguchi; Nami Asano; Kazuhiro Yoshida
Journal:  Rare Tumors       Date:  2010-03-31

8.  Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma.

Authors:  Yoshihiro Tanaka; Kazuhiro Yoshida; Atsuko Yamada; Toshiyuki Tanahashi; Naoki Okumura; Nobuhisa Matsuhashi; Kazuya Yamaguchi; Tatsuhiko Miyazaki
Journal:  Cancer Chemother Pharmacol       Date:  2016-02-20       Impact factor: 3.333

9.  Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.

Authors:  Yuko Kitagawa; Takashi Uno; Tsuneo Oyama; Ken Kato; Hiroyuki Kato; Hirofumi Kawakubo; Osamu Kawamura; Motoyasu Kusano; Hiroyuki Kuwano; Hiroya Takeuchi; Yasushi Toh; Yuichiro Doki; Yoshio Naomoto; Kenji Nemoto; Eisuke Booka; Hisahiro Matsubara; Tatsuya Miyazaki; Manabu Muto; Akio Yanagisawa; Masahiro Yoshida
Journal:  Esophagus       Date:  2018-08-31       Impact factor: 3.671

10.  Aggressive adenocarcinoma of the cervical esophagus: importance of a multidisciplinary approach.

Authors:  Adedayo Fashoyin; Gregory Hartig; William R Schelman; Mark Ritter; Rashmi Agni; Deepak V Gopal; Patrick R Pfau; Jennifer M Weiss
Journal:  Case Rep Gastrointest Med       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.